Toll Free Number Toll Free: 1800 103 1369 Email Us Email Us: customercare@canmoney.in
Market


Income Statement

You can view the Income Statement for the last 5 years.



INCOME STATEMENT

Accretion Pharmaceuticals Ltd.

GO
Market Cap. ( ₹ in Cr. ) 230.10 P/BV 4.21 Book Value ( ₹ ) 49.22
52 Week High/Low ( ₹ ) 220/62 FV/ML 10/600 P/E(X) 23.80
Book Closure EPS ( ₹ ) 8.70 Div Yield (%) 0.00
(₹ in Crs.)

ParticularsMar 26Mar 25Mar 24Mar 23Mar 22
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue10.0010.0010.0010.0010.00
      
      
INCOME     
Revenue From Operations [Net]89.6357.3833.6729.3822.29
Total Operating Revenues89.6357.3833.6729.3822.29
      
Other Income0.190.090.270.150.29
Total Revenue89.8257.4733.9429.5322.58
      
EXPENSES     
Cost Of Materials Consumed69.4243.7125.0623.6618.61
Changes In Inventories Of FG,WIP And Stock-In Trade-4.26-3.80-3.45-0.31-1.05
Employee Benefit Expenses4.573.672.622.471.96
Finance Costs0.871.441.151.081.02
Depreciation And Amortisation Expenses1.210.770.850.920.81
Other Expenses4.931.911.951.571.13
Total Expenses76.7347.7128.1829.3922.48
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax13.089.765.760.140.10
      
Profit/Loss Before Tax13.089.765.760.140.10
      
Tax Expenses-Continued Operations     
Current Tax3.362.601.860.040.02
Deferred Tax0.080.190.030.000.00
Tax For Earlier Years-0.020.180.000.000.00
Total Tax Expenses3.422.971.890.030.03
Profit/Loss After Tax And Before ExtraOrdinary Items9.676.793.880.100.08
      
Profit/Loss From Continuing Operations9.676.793.880.100.08
      
Profit/Loss For The Period9.676.793.880.100.08
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)9.038.489.690.000.00
Diluted EPS (Rs.)9.038.489.690.000.00